GTC
BMRN icon

Ghost Tree Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Ghost Tree Capital’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-185,000
Closed -$12.5M – 54
2019
Q3 		$12.5M Buy
+185,000
New +$14.2M 3.18% 15
2016
Q4 		– Sell
-60,000
Closed -$5.55M – 73
2016
Q3 		$5.55M Sell
60,000
-50,000
-45% -$4.71M 0.9% 40
2016
Q2 		$8.56M Buy
110,000
+70,000
+175% +$5.95M 2.47% 9
2016
Q1 		$3.3M Buy
+40,000
New +$3.25M 1.87% 22
2015
Q2 		– Sell
-35,000
Closed -$4.36M – 75
2015
Q1 		$4.36M Sell
35,000
-5,000
-13% -$530K 1.57% 22
2014
Q4 		$3.62M Buy
+40,000
New +$3.33M 1.74% 24
2014
Q1 		– Sell
-20,000
Closed -$1.41M – 67
2013
Q4 		$1.41M Buy
+20,000
New +$1.36M 0.87% 40

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return